Wnt/β-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor α

被引:212
作者
Armstrong, Victoria J. [1 ]
Muzylak, Mariusz [1 ]
Sunters, Andrew [1 ]
Zaman, Gul [1 ]
Saxon, Leanne K. [1 ]
Price, Joanna S. [1 ]
Lanyon, Lance E. [1 ]
机构
[1] Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
D O I
10.1074/jbc.M703224200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Wnt/beta-catenin pathway has been implicated in bone cell response to their mechanical environment. This response is the origin of the mechanism by which bone cells adjust bone architecture to maintain bone strength. Osteoporosis is the most widespread failure of this mechanism. The degree of osteoporotic bone loss in men and women is related to bio-available estrogen. Here we report that in osteoblastic ROS 17/2.8 cells and primary osteoblast cultures, a single short period of dynamic mechanical strain, as well as the glycogen synthase kinase-3 beta (GSK-3 beta) inhibitor LiCl, increased nuclear accumulation of activated beta-catenin and stimulated TCF/LEF reporter activity. This effect was blocked by the estrogen receptor ( ER) modulators ICI 182,780 and tamoxifen and was absent in primary osteoblast cultures from mice lacking ER alpha. Microarray expression data for 25,000 genes from total RNA extracted from tibiae of wild-type mice within 24 h of being loaded in vivo showed differential gene regulation between loaded and contralateral non-loaded bones of 10 genes established to be involved in the Wnt pathway. Only 2 genes were involved in loaded tibiae from mice lacking ER alpha (ER alpha(-/-)). Together these data suggest that Wnt/beta-catenin signaling contributes to bone cell early responses to mechanical strain and that its effectiveness requires ER alpha. Reduced effectiveness of bone cell responses to bone loading, associated with estrogen-related decline in ER alpha, may contribute to the failure to maintain structurally appropriate bone mass in osteoporosis in both men and women.
引用
收藏
页码:20715 / 20727
页数:13
相关论文
共 85 条
  • [1] Bone biomechanical properties in LRP5 mutant mice
    Akhter, MP
    Wells, DJ
    Short, SJ
    Cullen, DM
    Johnson, ML
    Haynatzki, GR
    Babij, P
    Allen, KM
    Yaworsky, PJ
    Bex, F
    Recker, RR
    [J]. BONE, 2004, 35 (01) : 162 - 169
  • [2] Age-related changes in human oestrogen receptor α function and levels in osteoblasts
    Ankrom, MA
    Patterson, JA
    d'Avis, PY
    Vetter, UK
    Blackman, MR
    Sponseller, PD
    Tayback, M
    Robey, PG
    Shapiro, JR
    Fedarko, NS
    [J]. BIOCHEMICAL JOURNAL, 1998, 333 : 787 - 794
  • [3] High bone mass in mice expressing a mutant LRP5 gene
    Babij, P
    Zhao, WG
    Small, C
    Kharode, Y
    Yaworsky, PJ
    Bouxsein, ML
    Reddy, PS
    Bodine, PVN
    Robinson, JA
    Bhat, B
    Marzolf, J
    Moran, RA
    Bex, F
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (06) : 960 - 974
  • [4] Evidence for cell-specific changes with age in expression of oestrogen receptor (ER) α and β in bone fractures from men and women
    Batra, GS
    Hainey, L
    Freemont, AJ
    Andrew, G
    Saunders, PTK
    Hoyland, JA
    Braidman, IP
    [J]. JOURNAL OF PATHOLOGY, 2003, 200 (01) : 65 - 73
  • [5] Controlling the false discovery rate in behavior genetics research
    Benjamini, Y
    Drai, D
    Elmer, G
    Kafkafi, N
    Golani, I
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2001, 125 (1-2) : 279 - 284
  • [6] Lithium induces gene expression through lymphoid enhancer-binding factor/T-cell factor responsive element in rat PC12 cells
    Bettini, E
    Magnani, E
    Terstappen, GC
    [J]. NEUROSCIENCE LETTERS, 2002, 317 (01) : 50 - 52
  • [7] SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
    Bezooijen, RL
    ten Dijke, P
    Papapoulos, SE
    Löwik, CWGM
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (03) : 319 - 327
  • [8] High bone density due to a mutation in LDL-receptor-related protein 5
    Boyden, LM
    Mao, JH
    Belsky, J
    Mitzner, L
    Farhi, A
    Mitnick, MA
    Wu, DQ
    Insogna, K
    Lifton, RP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (20) : 1513 - 1521
  • [9] Carvalho RS, 1998, J CELL BIOCHEM, V70, P376, DOI 10.1002/(SICI)1097-4644(19980901)70:3<376::AID-JCB11>3.0.CO
  • [10] 2-J